Comment on: Interpreting data on inhibitor development from previously untreated patient studies, beware of premature conclusions
Author:
- 13 July 2018
- journal article
- letter
- Published by Wiley in Haemophilia
- Vol. 24 (4) , E273-E275
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Interpreting data on inhibitor development from previously untreated patient studies, beware of premature conclusionsHaemophilia, 2018
- Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysisBlood, 2017
- Immunogenicity, efficacy and safety of Nuwiq® (human‐cl rhFVIII) in previously untreated patients with severe haemophilia A—Interim results from the NuProtect StudyHaemophilia, 2017
- A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia ANew England Journal of Medicine, 2016